Announcement of the Advisory Panel on Outreach and Education (APOE) In-Person Meeting, 55700-55702 [2023-17569]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
55700
Federal Register / Vol. 88, No. 157 / Wednesday, August 16, 2023 / Notices
Requirements, Cost Principles, and
Audit Requirements for Federal
Awards,’’ (Uniform Guidance) to have
audits conducted of their federal award
expenditures, and to file the resulting
reporting packages (Single Audit
reports) and data collection Form SF–
SAC (Form) with the Federal Audit
Clearinghouse. The Form SF–SAC is
appendix X to 2 CFR part 200.
The Single Audit process is the
primary method Federal agencies and
pass-through entities use to provide
oversight of Federal awards and reduce
risk of non-compliance and improper
payments. This oversight includes
following up on audit findings and
questioned costs.
The Office of Management and Budget
has historically designated the U.S.
Census Bureau (Census) as the FAC, to
serve as the government-wide repository
of record for Single Audit reports
collected under OMB control number
0607–0518. At the direction of OMB,
GSA will become the new FAC
repository of record, by September 30,
2023, with collection of Single Audits
with fiscal periods ending in 2023 and
later. GSA will also begin data
collection of 2016–2022 Single Audit
reports currently collected by Census.
All of these collections will be
conducted under this PRA clearance
application.
Single Audit reports under this
clearance will be collected
electronically through GSA’s new FAC
internet collection portal at https://
www.fac.gov/.
There are few proposed changes to the
existing data elements and data
collection method in this clearance.
Planned changes are intended to make
the reporting process easier, improve
data integrity, and ensure compliance
with the GREAT Act. All changes listed
below are intended to take effect for all
audit years collected by GSA, unless
specified otherwise.
The proposed changes include:
• end collection of the DUNS number
• upload the majority of data via
templates rather than graphical user
interface (GUI) in the initial GSA
system, subject to creation of a GUI for
additional data submission options
before expiration of this proposed
clearance (collection items are not
changing, just the means of collection)
• collect auditee’s Unique Entity
Identifier (UEI) for audits with fiscal
periods ending in 2016–2021 (already
approved to be collected for audits with
fiscal periods 2022 and future)
• when possible, import the auditee
name and address directly from
SAM.gov (when the auditee’s UEI is
entered, their auditee name and address
VerDate Sep<11>2014
19:39 Aug 15, 2023
Jkt 259001
will be pulled from SAM.gov into Part
I of the Form)
• update terminology, similar to the
following, in order to be in compliance
with the GREAT Act: change ‘‘award’’
to ‘‘federal award’’; ‘‘CFDA’’ to
‘‘Assistance Listing’’
• clarify on-screen and/or Form
instructions to improve data collection
and accuracy, as part of the creation of
an updated data collection and
dissemination system
B. Annual Reporting Burden
Respondents: 90,000 (45,000 auditees
and 45,000 auditors.
Responses per Respondent: 1.
Total Annual Responses: 90,000
(45,000 auditees and 45,000 auditors).
Hours per Response: 100 hours for
each of the 450 large respondents and
21 hours for each of the 89,550 small
respondents.
Total Burden Hours: 1,925,550.
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of the U.S. Department of
Health and Human Services (HHS) (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) on opportunities to
enhance the effectiveness of consumer
education strategies concerning the
Health Insurance Marketplace®,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP). This
meeting is open to the public.
DATES:
Meeting Date: Thursday, September
21, 2023 from 8:30 a.m. to 4:00 p.m.
eastern daylight time (e.d.t).
Deadline for Meeting Registration,
Presentations, Special
Accommodations, and Comments:
Thursday, September 7, 2023, 5:00 p.m.
(e.d.t).
C. Public Comments
ADDRESSES:
A 60-day notice published in the
Federal Register at 87 FR 78684 on
December 22, 2022. Four comments
were received. To view a summary of
the comments and responses, go to
https://www.regulations.gov, search for
‘‘OMB control number 3090–XXXX
Federal Audit Clearinghouse’’, click
‘‘Open Docket’’, and view ‘‘Supporting
Documents’’.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 3090–XXXX, Federal Audit
Clearinghouse, in all correspondence.
Meeting Location: U.S. Department of
Health & Human Services, Hubert H.
Humphrey Building, 200 Independence
Avenue SW, Washington, DC 20201.
Presentations and Written Comments:
Presentations and written comments
should be submitted to: Lisa Carr
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 200
Independence Avenue SW, Mailstop
325G HHH, Washington, DC 20201,
202–690–5742, or via email at APOE@
cms.hhs.gov.
Registration: Persons wishing to
attend this meeting must register at the
website https://CMS-APOESeptember2023.rsvpify.com or by
contacting the DFO listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice, by the date listed in the
DATES section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
contact the DFO at the address listed in
the ADDRESSES section of this notice by
the date listed in the DATES section of
this notice.
Lesley Briante,
Deputy Chief Information Officer.
[FR Doc. 2023–17518 Filed 8–15–23; 8:45 am]
BILLING CODE 6820–AB–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7072–N]
Announcement of the Advisory Panel
on Outreach and Education (APOE) InPerson Meeting
Centers for Medicare &
Medicaid Services (CMS), Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice announces the
next meeting of the APOE (the Panel) in
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Lisa
Carr, Designated Federal Official, Office
of Communications, 200 Independence
Avenue SW, Mailstop 325G HHH,
Washington, DC 20201, 202–690–5742,
or via email at APOE@cms.hhs.gov.
Additional information about the
APOE is available at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press
inquiries are handled through the CMS
Press Office at (202) 690–6145.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\16AUN1.SGM
16AUN1
Federal Register / Vol. 88, No. 157 / Wednesday, August 16, 2023 / Notices
I. Background and Charter Renewal
Information
lotter on DSK11XQN23PROD with NOTICES1
A. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of the
Federal Advisory Committee Act
(FACA) (Pub. L. 92–463), as amended (5
U.S.C. appendix 2), which sets forth
standards for the formation and use of
federal advisory committees. The Panel
is authorized by section 1114(f) of the
Social Security Act (the Act) (42 U.S.C.
1314(f)) and section 222 of the Public
Health Service Act (42 U.S.C. 217a).
The Panel, which was first chartered
in 1999, advises and makes
recommendations to the Secretary of the
U.S. Department of Health and Human
Services (the Department) and the
Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
the effective implementation of national
Medicare, Medicaid, Children’s Health
Insurance Program (CHIP) and Health
Insurance Marketplace outreach and
education programs.
The APOE has focused on a variety of
laws, including the Medicare
Modernization Act of 2003 (Pub. L. 108–
173), and the Affordable Care Act
(Patient Protection and Affordable Care
Act, (Pub. L. 111–148) and Health Care
and Education Reconciliation Act of
2010 (Pub. L. 111–152)).
The APOE helps the Department
determine the best communication
channels and tactics for various
programs and priorities, as well as new
rules and laws. In the coming years, we
anticipate the American Rescue Plan,
the Inflation Reduction Act, and the
SUPPORT Act will be some of the topics
the Panel will discuss. The Panel will
provide feedback to CMS staff on
outreach and education strategies,
communication tools and messages and
how to best reach minority, vulnerable
and Limited English Proficiency
populations.
B. Charter Renewal
The Panel’s charter was renewed on
January 19, 2023, and will terminate on
January 19, 2025, unless renewed by
appropriate action. The Charter can be
found at https://www.cms.gov/
regulations-and-guidance/guidance/
faca/apoe.
In accordance with the renewed
charter, the APOE will advise the
Secretary and the CMS Administrator
concerning optimal strategies for the
following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, the CHIP, and
VerDate Sep<11>2014
19:39 Aug 15, 2023
Jkt 259001
coverage available through the Health
Insurance Marketplace® and other CMS
programs.
• Enhancing the federal government’s
effectiveness in informing Medicare,
Medicaid, CHIP, or the Health Insurance
Marketplace® consumers, issuers,
providers, and stakeholders, pursuant to
education and outreach programs
regarding these programs, including
public-private partnerships to leverage
the resources of the private sector in
educating beneficiaries, providers,
partners and stakeholders.
• Expanding outreach to minority and
underserved communities, including
racial and ethnic minorities, in the
context of Medicare, Medicaid, CHIP,
and the Health Insurance Marketplace®
education programs and other CMS
programs as designated.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
• Building and leveraging existing
community infrastructure for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
The current members of the Panel as
of June 22, 2023, are as follows:
• Mitchell Balk, President, The Mt.
Sinai Health Foundation.
• Ted Henson, Director of Health
Center Performance and Innovation,
National Association of Community
Health Centers.
• Joan Ilardo, Director of Research
Initiatives, Michigan State University,
College of Human Medicine.
• Lydia Isaac, Vice President for
Health Equity and Policy, National
Urban League.
• Vacheria Keys, Director of Policy
and Regulatory Affairs, National
Association of Community Health
Centers.
• Daisy Kim, Principal Legislative
Analyst, University of California
System.
• Erin Loubier, Senior Director for
Health and Legal Integration and
Payment Innovation, Whitman-Walker
Health.
• Dr. Alister Martin, CEO, A Healthier
Democracy; Physician, Massachusetts
General Hospital; Assistant Professor,
Harvard Medical School.
• Cori McMahon, Behavioral
Medicine Psychologist and Digital
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
55701
Health Clinical Leader, Cooper
University Health Care.
• Alan Meade, Director of
Rehabilitation Services, Holston
Medical Group.
• Neil Meltzer, President and CEO,
LifeBridge Health.
• Dr. Carol Podgorski, Professor of
Psychiatry, Associate Chair of Academic
Affairs, University of Rochester Medical
Center.
• Melanie Prince, President/CEO
MAPYourWay, LLC; Immediate Past
President, Case Management Society of
America.
• Jina Ragland, Associate State
Director of Advocacy and Outreach,
AARP Nebraska.
• Morgan Reed, Executive Director,
Association for Competitive
Technology.
• Carrie Rogers, Associate Director,
Community Catalyst.
• Mina Schultz, Health Policy and
Advocacy Manager, Young Invincibles.
• Matthew Snider, JD, Senior Policy
Analyst, Unidos US.
• Daniel Spirn, Vice President,
Government Relations, Utilization
Review Accreditation Commission.
• Emily Whicheloe, Director of
Education, Medicare Rights Center.
II. Meeting Format and Agenda
In accordance with section 10(a) of
the FACA, this notice announces a
meeting of the APOE. The agenda for
the September 21, 2023 meeting will
include the following:
• Welcome and opening remarks from
CMS leadership
• Recap of the previous (June 22, 2023)
meeting
• Presentations on CMS programs,
initiatives, and priorities; discussion
of panel recommendations
• An opportunity for public comment
• Meeting adjourned
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
The meeting is open to the public, but
attendance is limited to the space
available. Persons wishing to attend this
E:\FR\FM\16AUN1.SGM
16AUN1
55702
Federal Register / Vol. 88, No. 157 / Wednesday, August 16, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
meeting must register at the following
weblink https://CMS-APOESeptember2023.rsvpify.com by
contacting the DFO at the address or
telephone number listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice by the date specified in the
DATES section of this notice.
This meeting will be held in a federal
government building, the Hubert H.
Humphrey (HHH) Building; therefore,
federal security measures are applicable.
The REAL ID Act of 2005 (Pub. L.
109–13) establishes minimum standards
for the issuance of state-issued driver’s
licenses and identification (ID) cards. It
prohibits federal agencies from
accepting an official driver’s license or
ID card from a state for any official
purpose unless the Secretary of the
Department of Homeland Security
determines that the state meets these
standards. Beginning October 2015,
photo IDs (such as a valid driver’s
license) issued by a state or territory not
in compliance with the Real ID Act will
not be accepted as identification to enter
federal buildings. Visitors from these
states/territories will need to provide
alternative proof of identification (such
as a valid passport) to gain entrance into
federal buildings. The current list of
states from which a federal agency may
accept driver’s licenses for an official
purpose is found at https://www.dhs.gov/
real-id-enforcement-brief.
We recommend that confirmed
registrants arrive reasonably early, but
no earlier than 45 minutes prior to the
start of the meeting, to allow additional
time to clear security. Security measures
include the following:
• Presentation of a government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection, via metal detector or
other applicable means, of all persons
entering the building. We note that all
items brought into the HHH Building,
whether personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting.
IV. Collection of Information
This document does not impose
information collection requirements,
VerDate Sep<11>2014
19:39 Aug 15, 2023
Jkt 259001
that is, reporting, recordkeeping, or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Evell J. Barco Holland, who
is the Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: August 11, 2023.
Evell J. Barco Holland,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2023–17569 Filed 8–15–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–D–1275]
Demonstrating Bioequivalence for
Type A Medicated Articles Containing
Active Pharmaceutical Ingredient(s)
Considered To Be Poorly Soluble in
Aqueous Media, That Exhibit Little to
No Systemic Bioavailability, and Are
Locally Acting; Draft Guidance for
Industry; Availability; Reopening of the
Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Notice of availability; reopening
of the comment period.
ACTION:
The Food and Drug
Administration (FDA or the Agency) is
reopening the comment period for the
notice of availability that published in
the Federal Register of June 8, 2023. In
that notice, FDA requested comments
on the draft guidance for industry (GFI)
#279 entitled ‘‘Demonstrating
Bioequivalence for Type A Medicated
Articles Containing Active
Pharmaceutical Ingredient(s)
Considered To Be Poorly Soluble in
Aqueous Media, That Exhibit Little to
No Systemic Bioavailability, and Are
Locally Acting.’’ The Agency is taking
this action in response to a request for
an extension to allow interested persons
additional time to develop and submit
comments.
DATES: FDA is reopening the comment
period on the notice of availability
published June 8, 2023 (88 FR 37551).
Submit either electronic or written
SUMMARY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
comments on the draft guidance by
October 16, 2023 to ensure that the
Agency considers your comments on
this draft guidance before it begins work
on the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2023–D–1275 for ‘‘Demonstrating
Bioequivalence for Type A Medicated
Articles Containing Active
Pharmaceutical Ingredient(s)
Considered To Be Poorly Soluble in
Aqueous Media, That Exhibit Little to
No Systemic Bioavailability, and Are
Locally Acting.’’ Received comments
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 88, Number 157 (Wednesday, August 16, 2023)]
[Notices]
[Pages 55700-55702]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17569]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7072-N]
Announcement of the Advisory Panel on Outreach and Education
(APOE) In-Person Meeting
AGENCY: Centers for Medicare & Medicaid Services (CMS), Health and
Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the APOE (the Panel)
in accordance with the Federal Advisory Committee Act. The Panel
advises and makes recommendations to the Secretary of the U.S.
Department of Health and Human Services (HHS) (the Secretary) and the
Administrator of the Centers for Medicare & Medicaid Services (CMS) on
opportunities to enhance the effectiveness of consumer education
strategies concerning the Health Insurance Marketplace[supreg],
Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
This meeting is open to the public.
DATES:
Meeting Date: Thursday, September 21, 2023 from 8:30 a.m. to 4:00
p.m. eastern daylight time (e.d.t).
Deadline for Meeting Registration, Presentations, Special
Accommodations, and Comments: Thursday, September 7, 2023, 5:00 p.m.
(e.d.t).
ADDRESSES:
Meeting Location: U.S. Department of Health & Human Services,
Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC
20201.
Presentations and Written Comments: Presentations and written
comments should be submitted to: Lisa Carr Designated Federal Official
(DFO), Office of Communications, Centers for Medicare & Medicaid
Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC
20201, 202-690-5742, or via email at [email protected].
Registration: Persons wishing to attend this meeting must register
at the website https://CMS-APOE-September2023.rsvpify.com or by
contacting the DFO listed in the FOR FURTHER INFORMATION CONTACT
section of this notice, by the date listed in the DATES section of this
notice. Individuals requiring sign language interpretation or other
special accommodations should contact the DFO at the address listed in
the ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal
Official, Office of Communications, 200 Independence Avenue SW,
Mailstop 325G HHH, Washington, DC 20201, 202-690-5742, or via email at
[email protected].
Additional information about the APOE is available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE. Press
inquiries are handled through the CMS Press Office at (202) 690-6145.
SUPPLEMENTARY INFORMATION:
[[Page 55701]]
I. Background and Charter Renewal Information
A. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5 U.S.C. appendix 2), which sets forth
standards for the formation and use of federal advisory committees. The
Panel is authorized by section 1114(f) of the Social Security Act (the
Act) (42 U.S.C. 1314(f)) and section 222 of the Public Health Service
Act (42 U.S.C. 217a).
The Panel, which was first chartered in 1999, advises and makes
recommendations to the Secretary of the U.S. Department of Health and
Human Services (the Department) and the Administrator of the Centers
for Medicare & Medicaid Services (CMS) on the effective implementation
of national Medicare, Medicaid, Children's Health Insurance Program
(CHIP) and Health Insurance Marketplace outreach and education
programs.
The APOE has focused on a variety of laws, including the Medicare
Modernization Act of 2003 (Pub. L. 108-173), and the Affordable Care
Act (Patient Protection and Affordable Care Act, (Pub. L. 111-148) and
Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-
152)).
The APOE helps the Department determine the best communication
channels and tactics for various programs and priorities, as well as
new rules and laws. In the coming years, we anticipate the American
Rescue Plan, the Inflation Reduction Act, and the SUPPORT Act will be
some of the topics the Panel will discuss. The Panel will provide
feedback to CMS staff on outreach and education strategies,
communication tools and messages and how to best reach minority,
vulnerable and Limited English Proficiency populations.
B. Charter Renewal
The Panel's charter was renewed on January 19, 2023, and will
terminate on January 19, 2025, unless renewed by appropriate action.
The Charter can be found at https://www.cms.gov/regulations-and-
guidance/guidance/faca/apoe.
In accordance with the renewed charter, the APOE will advise the
Secretary and the CMS Administrator concerning optimal strategies for
the following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, the CHIP, and coverage available through the Health Insurance
Marketplace[supreg] and other CMS programs.
Enhancing the federal government's effectiveness in
informing Medicare, Medicaid, CHIP, or the Health Insurance
Marketplace[supreg] consumers, issuers, providers, and stakeholders,
pursuant to education and outreach programs regarding these programs,
including public-private partnerships to leverage the resources of the
private sector in educating beneficiaries, providers, partners and
stakeholders.
Expanding outreach to minority and underserved
communities, including racial and ethnic minorities, in the context of
Medicare, Medicaid, CHIP, and the Health Insurance Marketplace[supreg]
education programs and other CMS programs as designated.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructure
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
prevention services, envisioned under the Affordable Care Act.
The current members of the Panel as of June 22, 2023, are as
follows:
Mitchell Balk, President, The Mt. Sinai Health Foundation.
Ted Henson, Director of Health Center Performance and
Innovation, National Association of Community Health Centers.
Joan Ilardo, Director of Research Initiatives, Michigan
State University, College of Human Medicine.
Lydia Isaac, Vice President for Health Equity and Policy,
National Urban League.
Vacheria Keys, Director of Policy and Regulatory Affairs,
National Association of Community Health Centers.
Daisy Kim, Principal Legislative Analyst, University of
California System.
Erin Loubier, Senior Director for Health and Legal
Integration and Payment Innovation, Whitman-Walker Health.
Dr. Alister Martin, CEO, A Healthier Democracy; Physician,
Massachusetts General Hospital; Assistant Professor, Harvard Medical
School.
Cori McMahon, Behavioral Medicine Psychologist and Digital
Health Clinical Leader, Cooper University Health Care.
Alan Meade, Director of Rehabilitation Services, Holston
Medical Group.
Neil Meltzer, President and CEO, LifeBridge Health.
Dr. Carol Podgorski, Professor of Psychiatry, Associate
Chair of Academic Affairs, University of Rochester Medical Center.
Melanie Prince, President/CEO MAPYourWay, LLC; Immediate
Past President, Case Management Society of America.
Jina Ragland, Associate State Director of Advocacy and
Outreach, AARP Nebraska.
Morgan Reed, Executive Director, Association for
Competitive Technology.
Carrie Rogers, Associate Director, Community Catalyst.
Mina Schultz, Health Policy and Advocacy Manager, Young
Invincibles.
Matthew Snider, JD, Senior Policy Analyst, Unidos US.
Daniel Spirn, Vice President, Government Relations,
Utilization Review Accreditation Commission.
Emily Whicheloe, Director of Education, Medicare Rights
Center.
II. Meeting Format and Agenda
In accordance with section 10(a) of the FACA, this notice announces
a meeting of the APOE. The agenda for the September 21, 2023 meeting
will include the following:
Welcome and opening remarks from CMS leadership
Recap of the previous (June 22, 2023) meeting
Presentations on CMS programs, initiatives, and priorities;
discussion of panel recommendations
An opportunity for public comment
Meeting adjourned
Individuals or organizations that wish to make a 5-minute oral
presentation on an agenda topic should submit a written copy of the
oral presentation to the DFO at the address listed in the ADDRESSES
section of this notice by the date listed in the DATES section of this
notice. The number of oral presentations may be limited by the time
available. Individuals not wishing to make an oral presentation may
submit written comments to the DFO at the address listed in the
ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
The meeting is open to the public, but attendance is limited to the
space available. Persons wishing to attend this
[[Page 55702]]
meeting must register at the following weblink https://CMS-APOE-September2023.rsvpify.com by contacting the DFO at the address or
telephone number listed in the FOR FURTHER INFORMATION CONTACT section
of this notice by the date specified in the DATES section of this
notice.
This meeting will be held in a federal government building, the
Hubert H. Humphrey (HHH) Building; therefore, federal security measures
are applicable.
The REAL ID Act of 2005 (Pub. L. 109-13) establishes minimum
standards for the issuance of state-issued driver's licenses and
identification (ID) cards. It prohibits federal agencies from accepting
an official driver's license or ID card from a state for any official
purpose unless the Secretary of the Department of Homeland Security
determines that the state meets these standards. Beginning October
2015, photo IDs (such as a valid driver's license) issued by a state or
territory not in compliance with the Real ID Act will not be accepted
as identification to enter federal buildings. Visitors from these
states/territories will need to provide alternative proof of
identification (such as a valid passport) to gain entrance into federal
buildings. The current list of states from which a federal agency may
accept driver's licenses for an official purpose is found at https://www.dhs.gov/real-id-enforcement-brief.
We recommend that confirmed registrants arrive reasonably early,
but no earlier than 45 minutes prior to the start of the meeting, to
allow additional time to clear security. Security measures include the
following:
Presentation of a government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection, via metal detector or other applicable means,
of all persons entering the building. We note that all items brought
into the HHH Building, whether personal or for the purpose of
presentation or to support a presentation, are subject to inspection.
We cannot assume responsibility for coordinating the receipt, transfer,
transport, storage, set up, safety, or timely arrival of any personal
belongings or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting.
IV. Collection of Information
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. chapter 35).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Evell J. Barco Holland, who is the Federal
Register Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: August 11, 2023.
Evell J. Barco Holland,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2023-17569 Filed 8-15-23; 8:45 am]
BILLING CODE 4120-01-P
